BRD2 and polycystic ovary syndrome: MI used in women with PCOS caused a reduction in the total number of units and number of days of FSH stimulation, reducing estradiol (E2) levels measured the day before human chorionic gonadotropin (hCG) administration, allowing a decreased risk of hyperstimulation syndrome [70].